The total return over the past 12 months is -93.24% vs. +16.94% for the S&P 500. So far it's up -86.05% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (93.24%) | (54.15%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (93.24%) | (54.15%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
| Year | Start price | End price | CVKD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.78 | $0.95 | (86.05%) | +14.51% | (100.56%) |
| 2025 | $14.49 | $6.78 | (53.21%) | +17.72% | (70.93%) |
| 2024 | $11.10 | $14.49 | +30.54% | +24.89% | +5.65% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
